Evidence map›Paper›PMID 38899057›Full record

ArticleFrontiers in neurology2024

Towards a lifelong personalized brain health program: empowering individuals to define, pursue, and monitor meaningful outcomes.

Stina Saunders, Joyce Gomes-Osman, Ali Jannati, Marissa Ciesla, Russell Banks, John Showalter, Graciela Muniz-Terrera, Saturnino Luz, Craig Ritchie, Álvaro Pascual-Leone

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stina SaundersLinus Health Inc., Boston, MA, United States.
Joyce Gomes-OsmanLinus Health Inc., Boston, MA, United States.
Ali JannatiLinus Health Inc., Boston, MA, United States.
Marissa CieslaLinus Health Inc., Boston, MA, United States.
Russell BanksLinus Health Inc., Boston, MA, United States.
John ShowalterLinus Health Inc., Boston, MA, United States.
Graciela Muniz-TerreraOhio University Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, United States.
Saturnino LuzUsher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Craig RitchieScottish Brain Sciences, Edinburgh, United Kingdom.
Álvaro Pascual-LeoneLinus Health Inc., Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Incorporating person-centered outcomes into clinical trials for neurodegenerative diseases has been challenging due to a deficiency in quantitative measures. Meanwhile, the integration of personally meaningful treatment targets in clinical practice remains qualitative, failing to truly inform evaluations, therapeutic interventions and longitudinal monitoring and support. We discuss the current advances and future directions in capturing individualized brain health outcomes and present an approach to integrate person-centered outcome in a scalable manner. Our approach stems from the evidence-based electronic Person-Specific Outcome Measure (ePSOM) program which prompts an individual to define personally meaningful treatment priorities and report level of confidence in managing items that matter to the individual the most (e.g., "Do I feel confident in my ability to contribute to a conversation?"). Deployed either as a single version (person only) or a dyad version (person and care partner), our proposed tool could be used as an endpoint in clinical trials, offering proof of meaningful intervention benefits and in clinical practice, by establishing an anchor for the therapeutic objectives sought by the individual.

Indexed as

Alzheimer’s diseaseclinical meaningfulnessmild cognitive impairmentoutcome measurespatient reported outcomes

Identifiers

PMID38899057
PMCPMC11186480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.